DPP4 and metabolic dysfunction-associated steatotic liver disease: The aim of the current work was to examine whether DPP-4 inhibition in a diet-induced high-fat feeding NASH model shows efficacy in prevention of progressive NAFLD features at histological and gene-expression levels, compared with controls and sulphonylurea gliclazide treatment.